je.st
news
UPDATE 1-FDA panel votes to expand use of Vertex cystic fibrosis drug
2014-10-22 07:30:16| Biotech - Topix.net
A U.S. Food and Drug Administration advisory panel on Tuesday voted 13-2 to recommend expanding approval of Vertex Pharmaceuticals Inc's cystic fibrosis drug Kalydeco to include a wider range of patients with the rare lung disease, the company said. The panel of experts said Kalydeco should be approved for patients ages 6 and older with a specific mutation of the R117H gene, of which there are about 500 people in the United States.
Tags: update
panel
expand
drug
Category:Biotechnology and Pharmaceuticals